MRCH1

The S&P 500 and the Nasdaq chain losses following the rise in unemployment insurance claims

The S&P 500 and the Nasdaq chain losses following the rise in unemployment insurance claims

Weekly jobless claims rise in line with estimates Moderna and Pfizer in place as FDA clears updated COVID boosters Exxon climbs after strengthening its buyback program Indices up: Dow 0.55%, S&P 0.75%, Nasdaq 1.13% Dec 8 (Reuters) – The S&P 500 (.SPX) ended higher on Thursday, ending a five-game losing streak as investors interpreted data …

The S&P 500 and the Nasdaq chain losses following the rise in unemployment insurance claims Read More »

Roche's Alzheimer's drug fails in long-awaited trial

Roche’s Alzheimer’s drug fails in long-awaited trial

Trials show small benefit, but without statistical validity Roche setback leaves Biogen and Eisai as leaders in the field It’s up to Roche’s CEO-designate to revive development fortunes Roche shares down 3.4%, its development partner Morphosys down 29% Nov 14 (Reuters) – Roche’s (ROG.S) drug candidate for Alzheimer’s disease has not been shown to slow …

Roche’s Alzheimer’s drug fails in long-awaited trial Read More »